Regression of primary gastric diffuse large B-cell lymphoma after eradication of Helicobacter pylori.
Sugimoto
M
M
Department of Gastroenterology, Seirei Hamamatsu General Hospital, Japan.
Kajimura
M
M
Sato
Y
Y
Hanai
H
H
Kaneko
E
E
Kobayashi
H
H
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D019160:Endosonography; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000382:microbiology* / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000382:microbiology* / Q000473:pathology; D008297:Male; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000382:microbiology* / Q000473:pathology; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D005765:Gastrointestinal Agents